Clinical Trial Detail

NCT ID NCT02980029
Title Pharmacodynamic Effects of Fatty Acid Synthase (FASN) Inhibition With TVB-2640 in Resectable Colon Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements no
Sponsors Mark Evers
Indications

colon cancer

Therapies

TVB-2640

Age Groups: adult senior

No variant requirements are available.